ArticleFrontiers in oncology2023

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis.

Andrea Caddeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.